Mario Salazar-Páramo

Oct 31, 2023 | frontiersin.org | Susan F. Slovin |Mario Salazar-Páramo |Kelsey Barrell

IntroductionThe idiopathic inflammatory myopathies (IIM) constitute a diverse group of systemic autoimmune diseases, which include various subtypes such as immune-mediated necrotizing myopathy, sporadic inclusion body myositis, polymyositis (PM), dermatomyositis (DM) (1). The estimated prevalence of PM and DM ranges from 5 to 22 per 100,000 people, while the incidence rate among individuals at risk is approximately 1.2 to 19 million per year.